OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
672954

Luminescence Technology Corp

Specialty ChemicalsVerified

Luminescence Technology Corp has a fully diluted share count of 25,161,300 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. The company's liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available for Luminescence Technology Corp, as no financial performance data has been reported in the valuation snapshot. This prevents a comparison against industry_config preferred metrics for specialty chemicals companies, such as EBITDA margins or ROIC. Segment and geographic exposure data is not disclosed in the available source documents, preventing analysis of revenue concentration or regional risk factors. The company's growth trajectory cannot be quantified due to the absence of outlook data and revenue history in the input dataset. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments outstanding. No recent events, such as filings or transcripts, are available to inform near-term strategic or operational developments.

30-day price · 6729-16.40 (-23.4%)
Low$46.50High$80.00Close$53.60As of12 May, 00:00 UTC
Profile
CompanyLuminescence Technology Corp
Ticker6729.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Luminescence Technology Corp is a specialty chemicals company that develops and produces chemical products for industrial applications.

Classification. Luminescence Technology Corp is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.

Luminescence Technology Corp has a fully diluted share count of 25,161,300 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. The company's liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available for Luminescence Technology Corp, as no financial performance data has been reported in the valuation snapshot. This prevents a comparison against industry_config preferred metrics for specialty chemicals companies, such as EBITDA margins or ROIC. Segment and geographic exposure data is not disclosed in the available source documents, preventing analysis of revenue concentration or regional risk factors. The company's growth trajectory cannot be quantified due to the absence of outlook data and revenue history in the input dataset. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments outstanding. No recent events, such as filings or transcripts, are available to inform near-term strategic or operational developments.
Key takeaways
  • Luminescence Technology Corp operates in the specialty chemicals industry with no disclosed revenue segments or geographic exposure.
  • The company has no dilution risk from stock options or convertible securities, as basic and diluted shares are equal.
  • Liquidity risk cannot be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • No financial performance data is available to compare against industry benchmarks for profitability or returns.
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$84.2M$1.5M$5.9M$17.0M
FY-3$104.0M$13.4M$21.8M$8.5M
FY-2$107.9M$24.2M$25.3M$15.2M
FY-1$100.3M$11.1M$29.3M-$46.9M
FY0$112.9M$13.7M$17.4M-$3.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$353.3M$331.7M$197.0M
FY-3$357.7M$328.3M$198.8M
FY-2$365.7M$334.0M$187.9M
FY-1$381.2M$325.6M$196.4M
FY0$351.4M$317.8M$158.0M
PeriodOCFCapExFCFSBC
FY-4$26.2M-$5.7M$17.0M
FY-3$38.2M-$3.0M$8.5M
FY-2$39.0M-$4.2M$15.2M
FY-1$32.3M-$51.3M-$46.9M
FY0$28.1M-$8.1M-$3.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric6729Activity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:20 UTC#0c6430d3
Market quoteclose TWD 53.60 · shares 0.03B diluted
no public URL
2026-05-13 00:20 UTC#9d5dac2d
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:07 UTCJob: 772e25e3